Considerations for the Identification and Management of Geographic Atrophy: Recommendations from an Expert Panel

Carl D Regillo; Lisa M Nijm; Diana L Shechtman; Peter K Kaiser; Paul M Karpecki; Edwin H Ryan; Michael S Ip; Elizabeth Yeu; Terry Kim; Mohammad R Rafieetary; Eric D Donnenfeld

doi:10.2147/OPTH.S445755

Considerations for the Identification and Management of Geographic Atrophy: Recommendations from an Expert Panel

Clin Ophthalmol. 2024 Feb 2:18:325-335. doi: 10.2147/OPTH.S445755. eCollection 2024.

Authors

Affiliations

¹ Mid Atlantic Retina, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.
² Warrenville Eye Care and LASIK Center, Warrenville, IL, USA.
³ Eye Centers of South Florida, North Miami Beach, FL, USA.
⁴ Cole Eye Institute, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA.
⁵ Kentucky College of Optometry, University of Pikeville, Pikeville, KY, USA.
⁶ Retina Consultants of Minnesota, Edina, MN, USA.
⁷ Doheny Eye Center UCLA, Pasadena, CA, USA.
⁸ Virginia Eye Consultants, Norfolk, VA, USA.
⁹ Duke University, Durham, NC, USA.
¹⁰ Charles Retina Institute, Germantown, TN, USA.
¹¹ Ophthalmic Consultants of Long Island, Garden City, NY, USA.

Abstract

Newly approved treatments for patients with geographic atrophy are changing the treatment paradigm, highlighting the need for eye care providers (ECPs) to have a set of recommendations on how to best manage GA patients. Here, we outline how to identify various stages of age-related macular degeneration including geographic atrophy (GA) by examining optimal management scenarios implicating various ECPs and reviewing treatment considerations for patients with GA. Early identification of GA will lead to optimal patient outcomes, while a standardized management scenario will reduce clinical burden among ECPs treating patients with GA.

Keywords: age-related macular degeneration; patient care; retina; treatment.